JP2511611B2 - 眼圧降下用医薬組成物 - Google Patents

眼圧降下用医薬組成物

Info

Publication number
JP2511611B2
JP2511611B2 JP4043018A JP4301892A JP2511611B2 JP 2511611 B2 JP2511611 B2 JP 2511611B2 JP 4043018 A JP4043018 A JP 4043018A JP 4301892 A JP4301892 A JP 4301892A JP 2511611 B2 JP2511611 B2 JP 2511611B2
Authority
JP
Japan
Prior art keywords
dihydro
keto
ester
ethyl
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP4043018A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0565227A (ja
Inventor
隆司 上野
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AARU TETSUKU UENO KK
UENO SEIYAKU OYO KENKYUSHO KK
Original Assignee
AARU TETSUKU UENO KK
UENO SEIYAKU OYO KENKYUSHO KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AARU TETSUKU UENO KK, UENO SEIYAKU OYO KENKYUSHO KK filed Critical AARU TETSUKU UENO KK
Publication of JPH0565227A publication Critical patent/JPH0565227A/ja
Application granted granted Critical
Publication of JP2511611B2 publication Critical patent/JP2511611B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Ophthalmology & Optometry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP4043018A 1991-03-01 1992-02-28 眼圧降下用医薬組成物 Expired - Lifetime JP2511611B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP6132891 1991-03-01
JP3-61328 1991-03-01

Publications (2)

Publication Number Publication Date
JPH0565227A JPH0565227A (ja) 1993-03-19
JP2511611B2 true JP2511611B2 (ja) 1996-07-03

Family

ID=13167964

Family Applications (1)

Application Number Title Priority Date Filing Date
JP4043018A Expired - Lifetime JP2511611B2 (ja) 1991-03-01 1992-02-28 眼圧降下用医薬組成物

Country Status (11)

Country Link
US (1) US5547968A (enExample)
EP (1) EP0501678B1 (enExample)
JP (1) JP2511611B2 (enExample)
KR (1) KR100221369B1 (enExample)
AT (1) ATE137407T1 (enExample)
CA (1) CA2061907C (enExample)
DE (1) DE69210286T2 (enExample)
DK (1) DK0501678T3 (enExample)
ES (1) ES2089387T3 (enExample)
GR (1) GR3019820T3 (enExample)
TW (1) TW210287B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998019680A1 (en) * 1996-11-01 1998-05-14 Alcon Laboratories, Inc. Use of a combination of carbonic anhydrase inhibitors and prostaglandins for treating glaucoma
US6214381B1 (en) 1998-09-08 2001-04-10 Effcon, Inc. Methazolamide composition and method of use
US7128903B2 (en) * 2001-10-03 2006-10-31 Innovative Pharmaceutical Concepts (Ipc) Inc. Pharmaceutical preparations useful for treating tumors and lesions of the skin and the mucous membranes and methods and kits using same
US20040225014A1 (en) * 2003-02-14 2004-11-11 Sucampo Ag Method for treating ocular hypertension and glaucoma
TWI348386B (en) * 2003-08-12 2011-09-11 R Tech Ueno Ltd Composition and method for promoting hair growth
JP6193655B2 (ja) * 2012-07-13 2017-09-06 参天製薬株式会社 スルホンアミド化合物の組み合わせ
US9980946B1 (en) 2017-01-25 2018-05-29 Effcon Laboratories, Inc. Extended release methazolamide formulation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2053458T3 (es) * 1986-03-13 1994-08-01 Univ Columbia Utilizacion de prostaglandinas a, b y c y derivados de las mismas, para el tratamiento de la hipertension ocular y glaucoma.
EP0286903B2 (en) * 1987-04-03 2000-03-29 The Trustees Of Columbia University In The City Of New York Use of a prostaglandin in combination with an adrenergic blocking agent for reduction of intraocular pressure
GB2209939B (en) * 1987-09-18 1992-01-02 R Tech Ueno Ltd The use of 13,14-dihydro-15-keto-prostaglandins as ocular hypotensive agents
JPH0739343B2 (ja) * 1988-10-01 1995-05-01 株式会社アールテック・ウエノ 眼圧降下剤
ATE111736T1 (de) * 1988-10-01 1994-10-15 R Tech Ueno Ltd Okulare hypotensive mittel.

Also Published As

Publication number Publication date
TW210287B (enExample) 1993-08-01
CA2061907A1 (en) 1992-09-02
EP0501678A2 (en) 1992-09-02
DE69210286T2 (de) 1996-09-12
GR3019820T3 (en) 1996-08-31
ES2089387T3 (es) 1996-10-01
EP0501678B1 (en) 1996-05-01
DK0501678T3 (da) 1996-05-28
CA2061907C (en) 2003-04-08
US5547968A (en) 1996-08-20
ATE137407T1 (de) 1996-05-15
KR100221369B1 (ko) 1999-09-15
DE69210286D1 (de) 1996-06-05
JPH0565227A (ja) 1993-03-19
KR920017654A (ko) 1992-10-21
EP0501678A3 (en) 1992-12-16

Similar Documents

Publication Publication Date Title
US5432174A (en) Treatment of ocular hypertension
US5221763A (en) Prostaglandins of the F series
US5591887A (en) Prostaglandins of the F series
US5194429A (en) Ocular hypotensive agents
EP0289349A1 (en) Prostaglandins of the F series
JPH0680571A (ja) 眼圧降下剤
EP0580268B1 (en) Ocular hypotensive agents
EP0458588B1 (en) Treatment of ocular hypertension with a synergistic combination for ocular administration
JP2511587B2 (ja) 眼科用医薬組成物
JP2511585B2 (ja) 眼科用組成物
JP2511611B2 (ja) 眼圧降下用医薬組成物
JP2511586B2 (ja) 眼科用医薬組成物
US5236907A (en) Ocular hypotensive agents
JPH06107547A (ja) 眼科用組成物
US5175189A (en) Treatment of ocular hypertension with a synergistic combination for ophthalmic use
JP2515442B2 (ja) 膵臓疾患処置剤
US5523461A (en) Stabilization of a prostanoic acid compound
JP2839798B6 (ja) プロスタン酸化合物の安定化

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20080416

Year of fee payment: 12

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090416

Year of fee payment: 13

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100416

Year of fee payment: 14

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100416

Year of fee payment: 14

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110416

Year of fee payment: 15

EXPY Cancellation because of completion of term